Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026

Rhea-AI Summary

Corvus Pharmaceuticals (NASDAQ: CRVS) will host a conference call and webcast on August 6, 2026 at 4:30 pm ET (1:30 pm PT) to provide a business update and report its second quarter 2026 financial results.

According to Corvus Pharmaceuticals, domestic investors can join by dialing 1-800-717-1738, while international participants can use 1-646-307-1865 or an instant telephone access link. The live webcast will be available through the investor relations section of the company’s website, with a replay accessible for 90 days.

Market Context

Net Buying was recorded in recent insider activity, including 28,632 shares bought and none sold. Th...

Analysis

Net Buying was recorded in recent insider activity, including 28,632 shares bought and none sold. That platform context accompanies the earnings-date notice, while high short positioning is a risk to monitor.

Key Figures

Reporting date: August 6, 2026 Conference call time: 4:30 pm ET / 1:30 pm PT Replay availability: 90 days

3 metrics

Reporting date August 6, 2026 Second quarter 2026 financial results and business update

Conference call time 4:30 pm ET / 1:30 pm PT August 6, 2026

Replay availability 90 days Webcast replay on Corvus' website

Previous Earnings date Reports

5 past events · Latest: Mar 05 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 05	Fourth-quarter results date	Neutral	-1.6%	Scheduled fourth-quarter and full-year 2025 financial results conference call
Oct 28	Third-quarter results date	Neutral	+1.2%	Scheduled third-quarter 2025 financial results and business update
Jul 31	Second-quarter results date	Neutral	-1.7%	Scheduled second-quarter 2025 financial results conference call
Mar 17	Full-year results date	Neutral	-0.6%	Scheduled fourth-quarter and full-year 2024 financial results announcement
Nov 05	Third-quarter results date	Neutral	-4.9%	Scheduled third-quarter 2024 financial results conference call

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-specific history showed four of five prior earnings-date announcements followed by negative 24-hour reactions, with an average move of -1.53%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT

SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 6, 2026 at 4:30 pm ET (1:30 pm PT) to provide a business update and report second quarter 2026 financial results.

The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 90 days.

About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of immune diseases and cancer. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Soquelitinib is being evaluated in a registration Phase 3 clinical trial for relapsed/refractory PTCL and in a Phase 2 clinical trial for the treatment of atopic dermatitis. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com or follow the Company on LinkedIn.

INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
llea@corvuspharma.com

MEDIA CONTACT:
Julia Stern
Real Chemistry
+1-763-350-5223
jstern@realchemistry.com

FAQ

When will Corvus Pharmaceuticals (NASDAQ: CRVS) report its Q2 2026 financial results?

Corvus Pharmaceuticals will report its second quarter 2026 financial results on August 6, 2026. According to Corvus Pharmaceuticals, the company will discuss results and provide a business update during a conference call and webcast starting at 4:30 pm ET.

What time is the Corvus Pharmaceuticals Q2 2026 earnings conference call on August 6, 2026?

The Corvus Pharmaceuticals Q2 2026 conference call is at 4:30 pm ET on August 6, 2026. According to Corvus Pharmaceuticals, this corresponds to 1:30 pm PT, allowing investors in different U.S. time zones to participate live.

How can investors access the Corvus Pharmaceuticals (CRVS) Q2 2026 earnings call by phone?

Investors can access the Corvus Pharmaceuticals earnings call by dialing 1-800-717-1738 domestically or 1-646-307-1865 internationally. According to Corvus Pharmaceuticals, callers may also click an instant telephone access link provided for the event.

Where can I watch the Corvus Pharmaceuticals Q2 2026 earnings webcast?

The Corvus Pharmaceuticals Q2 2026 earnings webcast will be available on the company’s investor relations website. According to Corvus Pharmaceuticals, a live stream of the call will be hosted there for online participants.

Will a replay of the Corvus Pharmaceuticals (CRVS) August 6, 2026 webcast be available?

Yes, a replay of the Corvus Pharmaceuticals August 6, 2026 webcast will be available. According to Corvus Pharmaceuticals, investors can access the replay on the company’s website for 90 days after the live event.